You are here

lung cancer

OSI says Tarceva met goals in lung cancer trial

Yahoo/AP

Fri, 05/15/09 - 08:06 am

OSI Pharmaceuticals

Roche To Start New Trial With Tarceva In Lung Cancer

WSJ Online

Fri, 04/24/09 - 10:03 am

OSI Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer

Yahoo

Thu, 03/19/09 - 06:45 am

OSI Pharmaceuticals

Ariad's partner Merck initiates Phase II lung cancer trial

Pharmaceutical Business Review

Tue, 03/10/09 - 07:32 am

Ariad Pharmaceuticals

Genentech, OSI Rise After Lung Cancer Data

TheStreet.com

Tue, 02/3/09 - 06:14 am

OSI Pharmaceuticals

AstraZeneca’s Zactima for Lung Cancer May Win Over Regulators

Bloomberg

Mon, 01/26/09 - 07:30 pm

ImClone, Bristol-Myers withdraw FDA application for Erbitux use in a type of lung cancer

Yahoo/AP

Sat, 01/24/09 - 10:28 am

Bristol-Myers Squibb

Pages